Positive News SentimentPositive NewsNASDAQ:AFJK Aimei Health Technology (AFJK) Stock Price, News & Analysis $11.95 +0.05 (+0.42%) As of 11:45 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock About Aimei Health Technology Stock (NASDAQ:AFJK) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get AFJK alerts:Sign Up Key Stats Today's Range$11.95▼$12.0050-Day Range$11.74▼$43.0052-Week Range$6.75▼$130.37Volume4,308 shsAverage Volume21,060 shsMarket Capitalization$37.88 millionP/E Ratio73.94Dividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York. Read More Aimei Health Technology Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks11th Percentile Overall ScoreAFJK MarketRank™: Aimei Health Technology scored higher than 11% of companies evaluated by MarketBeat, and ranked 101st out of 118 stocks in the financial services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingAimei Health Technology has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageAimei Health Technology has only been the subject of 1 research reports in the past 90 days.Read more about Aimei Health Technology's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Aimei Health Technology is 74.38, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.83.Price to Earnings Ratio vs. SectorThe P/E ratio of Aimei Health Technology is 74.38, which means that it is trading at a more expensive P/E ratio than the Financial Services sector average P/E ratio of about 29.30. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.14% of the float of Aimei Health Technology has been sold short.Short Interest Ratio / Days to CoverAimei Health Technology has a short interest ratio ("days to cover") of 0.12, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aimei Health Technology has recently increased by 3.51%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAimei Health Technology does not currently pay a dividend.Dividend GrowthAimei Health Technology does not have a long track record of dividend growth. News and Social Media3.7 / 5News SentimentN/A News SentimentAimei Health Technology has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Financial Services companies.News Coverage This WeekMarketBeat has tracked 1 news article for Aimei Health Technology this week, compared to 4 articles on an average week.MarketBeat Follows2 people have added Aimei Health Technology to their MarketBeat watchlist in the last 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aimei Health Technology insiders have not sold or bought any company stock.Percentage Held by Insiders2.50% of the stock of Aimei Health Technology is held by insiders.Percentage Held by Institutions45.58% of the stock of Aimei Health Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Aimei Health Technology's insider trading history. Receive AFJK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aimei Health Technology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AFJK Stock News HeadlinesAIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORTMay 20, 2026 | globenewswire.comAimei Health Extends SPAC Deadline, Issues New NoteMay 18, 2026 | theglobeandmail.comTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.July 30 at 1:00 AM | Altimetry (Ad)AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED ANNUAL REPORTApril 21, 2026 | globenewswire.comLatest Aimei Health Technology Stock News | NASDAQ:AFJK | BenzingaApril 9, 2026 | benzinga.comAimei Health Technology Co., LtdApril 9, 2026 | edition.cnn.comAimei Health Technology Delays Annual 10-K FilingApril 3, 2026 | theglobeandmail.comAimei Health Extends Business Combination DeadlineJune 6, 2025 | tipranks.comSee More Headlines AFJK Stock Analysis - Frequently Asked Questions How have AFJK shares performed this year? Aimei Health Technology's stock was trading at $64.01 at the beginning of 2026. Since then, AFJK shares have decreased by 81.4% and is now trading at $11.90. How were Aimei Health Technology's earnings last quarter? Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) released its quarterly earnings results on Tuesday, June, 16th. The company reported $0.01 earnings per share for the quarter. How do I buy shares of Aimei Health Technology? Shares of AFJK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aimei Health Technology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aimei Health Technology investors own include Andretti Acquisition Corp. II (POLEU), Arogo Capital Acquisition (AOGO), Agriculture & Natural Solutions Acquisition (ANSC), Alpha Star Acquisition (ALSA), Alchemy Investments Acquisition Corp 1 (ALCY), AI Transportation Acquisition (AITR) and Aimfinity Investment Corp. I (AIMAU). Company Calendar Last Earnings6/16/2026Today7/30/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3w+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 For the last 3 weeks, AFJK's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinancial Services Industry UNCLASSIFIED Sub-IndustryTrading Current SymbolNASDAQ:AFJK Previous SymbolNASDAQ:AFJK CIK1979005 WebN/A Phone34-67-803-5200FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)$0.16 Trailing P/E Ratio73.94 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.06 million Net MarginsN/A Pretax MarginN/A Return on Equity-25.30% Return on Assets3.22% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.50 per share Price / Cash Flow24.07 Book Value($1.91) per share Price / Book-6.26Miscellaneous Outstanding Shares3,170,000Free Float3,087,000Market Cap$37.88 million OptionableN/A Beta0.55 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:AFJK) was last updated on 7/30/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredA $5 stock inside Kennedy Space Center?A small publicly traded company operates a specialized launch vehicle fleet inside the secure perimeter of Ken...Freedom Financial | SponsoredSpaceX just minted 4,400 millionairesSpaceX's $1.75 trillion IPO turned more than 4400 employees into millionaires, according to The New York Times...The Oxford Club | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBNZI Is Building an AI Growth EngineBanzai International (NASDAQ: BNZI) just earned a Zacks Rank 2 (Buy) upgrade, reflecting rising confidence in ...Huge Alerts | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredI found Rolls-Royce at $2 - now I see the same setup againIn 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had wri...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aimei Health Technology Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aimei Health Technology With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
